1620 Investment Advisors »

Astria Therapeutics shares owned by 1620 Investment Advisors

Quarter-by-quarter ownership of Astria Therapeutics (ATXS) shares owned by 1620 Investment Advisors from 13F filings

Historical chart of 1620 Investment Advisors investment in Astria Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Astria Therapeutics held by 1620 Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Astria Therapeutics by 1620 Investment Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $15k 2.0k 7.28
2025-06-30 $11k 2.0k 5.36

More positions owned by 1620 Investment Advisors

Spdr Portfolio Intermediate Term Corporate Bond Etf Etf (SPIB)
Spdr Msci Eafe Strategicfactors Etf Etf (QEFA)
Ishares 7-10 Year Treasury Bond Etf Etf (IEF)
JPMorgan Chase & Co. (JPM)
Tri Contl Corp Cef (TY)
Spdr Portfolio Short Term Treasury Etf Etf (SPTS)
Freedom 100 Emerging Markets Etf Etf (FRDM)
Ishares 1-5 Year Investment Grade Corporate Bond Etf Etf (IGSB)
Apple (AAPL)
TJX Companies (TJX)
Schwab Us Tips Etf Etf (SCHP)
Microsoft Corporation (MSFT)
Janus Henderson Securitized Income Etf Etf (JSI)
Raytheon Technologies Corp (RTX)
Taiwan Semiconductor Mfg (TSM)

View all positions for 1620 Investment Advisors

Top funds holding Astria Therapeutics

Perceptive Advisors
FMR
Vestal Point Capital
Fcpm Iii Services B.v.
Fairmount Funds Management
BlackRock
Millennium Management
TCG Crossover Management
Vanguard Group
VR Adviser
Jpmorgan Chase & Co
Vivo Capital
Rosalind Advisors
Driehaus Capital Management
Nantahala Capital Management

View all funds holding Astria Therapeutics